November 1, 2013
Fidelity Biosciences and REGENX Biosciences Launch Dimension Therapeutics to Develop and Commercialize Novel AAV Gene Therapy Products | Business Wire
Fidelity Biosciences and REGENX Biosciences today announced the formation of Dimension Therapeutics, a gene therapy…